Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophago-gastric Cancer × Panitumumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 100 Colonic Neoplasms 28 Rectal Neoplasms 25 Neoplasm Metastasis 18 Neoplasms 16 Esophageal Neoplasms 10 Pancreatic Neoplasms 9 Colorectal Cancer Metastatic 6 Cholangiocarcinoma 6 Carcinoma, Non-Small-Cell Lung 5 Gastrointestinal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Adenocarcinoma 2 Recurrence 1 Pancreatic Adenocarcinoma 1 Oesophago-gastric Cancer 1 Neoplasms, Second Primary 1 Kidney Neoplasms 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Exanthema 1 Esophageal Squamous Cell Carcinoma 1 Elderly Metastatic Colorectal Cancer Patients 1 Dihydropyrimidine Dehydrogenase Deficiency 1 Colorectal Adenocarcinoma Metastatic to the Liver 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡